Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-020570

Director sold 27,000 shares at $3.33 ($89,818)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Senderowicz Adrian Director 2024-06-13 Sale 10b5-1 −27,000 $3.33 $89,818 0 D
Open-market sales · 27,000 sh · avg $3.33 · $89,818
Loading xslF345X05/rdgdoc.xml…